RSG
65
-3
SE
60
-3
TMO
42
-6
MMM
35
-5
KIM
72
2
GRMN
67
-4
DTE
43
5
BA
47
2
CNP
54
10
INTU
58
-3
EXPD
43
-4
ROST
57
-3
GM
74
5
BEN
50
9
CA
22
-3
PFE
14
-7
A
37
-2
DHR
32
-6
SWK
50
-5
STI
45
26
RSG
65
-3
SE
60
-3
TMO
42
-6
MMM
35
-5
KIM
72
2
GRMN
67
-4
DTE
43
5
BA
47
2
CNP
54
10
INTU
58
-3
EXPD
43
-4
ROST
57
-3
GM
74
5
BEN
50
9
CA
22
-3
PFE
14
-7
A
37
-2
DHR
32
-6
SWK
50
-5
STI
45
26
Financhill
Back

AdvisorShares Insider Advantage ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
52

SURE
AdvisorShares Insider Advantage ETF

Last Price:
124.14
Seasonality Move:
4.83%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Buy
52
AdvisorShares Insider Advantage ETF (SURE) is a Buy

Is AdvisorShares Insider Advantage ETF a Buy, Sell or Hold?

  • The current AdvisorShares Insider Advantage ETF [SURE] share price is $123.68. The Score for SURE is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • SURE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SURE Stock Price Chart

What is AdvisorShares Insider Advantage ETF's stock price today?

  • The AdvisorShares Insider Advantage ETF share price today is $123.68
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SURE is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

SURE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.37 Buy
Relative Strength Index (14 RSI): 68.67 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (118.4 - 123.02) Buy
Bollinger Bands (100): (112.47 - 120.07) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

SURE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 123.56 Buy
20-day SMA: 120.55 Buy
50-day SMA: 119.06 Buy
200-day SMA: 114.15 Buy
8-day EMA: 122.92 Buy
20-day EMA: 121.41 Buy
50-day EMA: 119.34 Buy
200-day EMA: 113.35 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

AdvisorShares Insider Advantage ETF Earnings Growth & SURE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

AdvisorShares Insider Advantage ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):